Lakshmanan Govindan | Pharmacology | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Lakshmanan Govindan | Pharmacology | Best Researcher Award

Dr. Lakshmanan Govindan | Pharmacology | Best Researcher Award 

Assistant Professor, Saveetha Medical College and Hospital, India.

Dr. G. Lakshmanan is an Assistant Professor at Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai. With a strong background in phytochemistry and biotechnology, he has expertise in isolating bioactive compounds from medicinal plants, focusing on anticancer and antidiabetic activities. His research blends natural product chemistry with cutting-edge laboratory techniques.

Profile

Scopus

Google Scholar

Education

🎓 Dr. G. Lakshmanan holds a Ph.D. in Biotechnology with a thesis on “Isolation, Purification and Characterization of Antiproliferative Bioactive Compounds from Cleome viscosa Linn: An in vitro approach.” He earned his M.Phil. degree researching the “Bio-Decolourisation of Textile Dyes Using Bacillus cereus” and completed his M.Sc. with a study on the biochemical effects of industrial waste on Lycopersicum esculentum.

Professional Experience

👨‍🏫 Dr. Lakshmanan currently serves as an Assistant Professor at Saveetha Medical College. He has previously held positions at Sri Lakshmi Narayana Institute of Medical Sciences, Bharath Institute of Higher Education and Research, and Meenakshi Academy of Higher Education and Research. His teaching and research focus on medicinal plant biotechnology, anticancer, and antidiabetic studies.

Research Interests

🔬 Dr. Lakshmanan’s research interests lie in:

  • Isolation of bioactive compounds from medicinal plants.
  • Anticancer and antidiabetic properties of plant extracts.
  • Biosynthesis of silver nanoparticles.
  • Biodegradation of textile dyes.
  • Plant tissue culture techniques for medicinal applications.

Awards

🏆 Dr. Lakshmanan has been recognized with the Young Scientist Award in International Research Awards on Science, Technology, and Management from INSO Awards, among other accolades for his contributions to biotechnological research.

Publications

📚 Dr. Lakshmanan has contributed to numerous high-impact journals. Below are some of his recent publications:

  • Encapsulation of Phloroglucinol from Rosenvingea intricata Macroalgae with Zinc Oxide Nanoparticles against A549 Lung Cancer Cells. MDPI-Pharmaceutics (2024), Cited by 20, Impact Factor: 4.9.
  • Biogenic Production of Silver Nanoparticles Using Neocosmospora Solani Endophytic Fungal Extract: Their In Vitro Antibacterial and Anticancer Properties. Journal of Inorganic and Organometallic Polymers and Materials (2024), Cited by 15, Impact Factor: 3.9.
  • Antibacterial and Photo Dye Degradative Ability of Copper Oxide Nanoparticles from Pleurotus cystidiosus. IOP Nano Express (2024), Cited by 10, Impact Factor: 3.8.
  • A Comprehensive Review on Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications. Journal of Agriculture and Food Research (2024), Cited by 12, Impact Factor: 3.8.
  • Extraction, Purification, and Investigation of the Antibacterial Potential of Lysozyme Isolated from the Latex of Calotropis procera. European Food Research and Technology (2024), Cited by 8, Impact Factor: 3.3.

Conclusion:

Dr. G. Lakshmanan is a strong candidate for the Best Researcher Award. His significant contributions to medicinal plant research, nanotechnology, and cancer therapeutics, combined with his active role in academia and his robust publication record, make him a well-rounded researcher with an impressive trajectory. Expanding his international collaborations and focusing on translational aspects of his research could further elevate his academic standing.

Nallusamy Duraisamy | Phytochemistry | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Nallusamy Duraisamy | Phytochemistry | Best Researcher Award

Dr. Nallusamy Duraisamy | Phytochemistry | Best Researcher Award 

Research Scientist, Meenakshi Academy of Higher Education and Research (Deemed University) Chennai, Tamil Nadu, India.

Dr. Nallusamy Duraisamy is a dedicated research scientist currently working at Meenakshi Academy of Higher Education and Research, Tamil Nadu, India. With expertise in microbiology, biotechnology, and nanotechnology, his work focuses on molecular biology techniques, antimicrobial susceptibility, and advanced wound healing research. Dr. Nallusamy’s extensive career also includes roles as a Clinical Lab Manager, contributing to laboratory quality assurance and research monitoring.

Profile

Scopus

Google Scholar

Education

Dr. Nallusamy holds a Ph.D. in Microbiology-Biotechnology from the University of Madras (2013-2021), where his thesis received high commendation. He also completed an M.Sc. in Microbiology from Annamalai University (2010-2012) with an ‘A’ grade and a B.Sc. in Microbiology from Bharathidasan University (2007-2010), earning first-class honors.

Professional Experience

Currently, Dr. Nallusamy serves as a Research Scientist at Meenakshi Academy of Higher Education and Research since May 2023, where he specializes in executing research proposals, supervising student projects, and academic integrity. His previous roles include serving as a Clinical Lab Manager at Master Scan & Labs Pvt. Ltd. (2021-2023), overseeing lab operations, quality assurance, and staff training.

Research Interests

Dr. Nallusamy’s research interests encompass molecular biology, nanotechnology, microbial culture techniques, and biopolymer synthesis. He has worked extensively on the biomedical applications of astaxanthin, antimicrobial nanoparticle synthesis, and virus detection using advanced methods like AuNPs conjugated probes.

Awards and Fellowships

Dr. Nallusamy has received several accolades, including the International Research Internship Award (2018) at National Taiwan University of Science and Technology, focusing on biopolymer synthesis, and the DST-SERB Project Fellowship (2014-2016) for his research on virus detection techniques at the University of Madras.

Publications

Dr. Nallusamy has published numerous articles in reputed journals. Here are a few notable works:

      • Sundararaj et al.
        Title: Insight on the Health Benefits of Functional Food: Dark Chocolate
        Journal: Texila International Journal Of Public Health
        Status: Accepted for Publication
        Summary: This paper explores the various health benefits of dark chocolate as a functional food. The research emphasizes dark chocolate’s role in promoting heart health, improving cognitive function, and its potential antioxidant properties. It delves into the bioactive compounds present in dark chocolate that contribute to these health benefits.
      • Supriya et al.
        Title: Application of Probiotics in Cervical Cancer Infections to Enhance the Immune Response
        Journal: Microbial Pathogenesis
        Year: 2024
        DOI: 10.1016/J.Micpath.2024.106764
        Summary: This research examines how probiotics can be applied in the treatment of cervical cancer infections to boost the immune response. The study discusses the mechanisms by which probiotics modulate the immune system, highlighting their potential therapeutic role in improving outcomes for patients with cervical cancer-related infections.
      • Duraisamy et al.
        Title: Synthesis of Silver Nanoparticles Using Lyngbya majuscula Extract and Their Antibacterial Effects
        Journal: International Journal of Pharma and Biosciences
        Year: 2020
        DOI: 10.22376/ijpbs.2020.11.2.p83-91
        Summary: This paper discusses the synthesis of silver nanoparticles using the extract of Lyngbya majuscula, a species of cyanobacteria. It details the method of nanoparticle synthesis and evaluates the antibacterial effects of the silver nanoparticles against a range of pathogenic bacteria, highlighting the potential application of these nanoparticles in biomedical fields.

      These references offer insights into a variety of fields, from public health to microbiology and nanotechnology

      Conclusion

    Nallusamy Duraisamy presents a strong case for the Best Researcher Award given his extensive research output, interdisciplinary expertise, international recognition, and impactful contributions to biotechnology, nanotechnology, and cancer research. His work in developing biomedical applications such as wound healing and cancer treatments demonstrates real-world applications of his findings. To enhance his candidacy, a focus on expanding international collaborations, public engagement, and leadership roles could further strengthen his profile. Overall, Nallusamy’s achievements position him as a highly competitive candidate for the award.

MYTHILEESWARI LAKSHMIKANTHAN | immunology | Women Researcher Award

Posted on by sciencefatherLeave a Comment on MYTHILEESWARI LAKSHMIKANTHAN | immunology | Women Researcher Award

Mrs. MYTHILEESWARI LAKSHMIKANTHAN | immunology | Women Researcher Award 

Research scholar, University of Madras, India.

Mrs. Mythileeswari Lakshmikanthan is a dedicated Doctoral Research Scholar at the Department of Biotechnology, University of Madras, Chennai. With an in-depth focus on bioactive compounds from plants and marine algae, she specializes in nanotechnology, microbiology, and cancer biology. Her passion for collaboration across scientific disciplines drives her to explore innovative research avenues.

Profile

Scopus

Google Scholar

ORCiD

Education

Mrs. Mythileeswari’s academic journey is anchored at the University of Madras, where she is currently pursuing a Ph.D. in Biotechnology (2023). She holds an M.Phil. in Botany (2008), an M.Sc. in Botany (2007), a B.Ed. in Biological Science (2004), and a B.Sc. in Botany (2003). Her educational foundation reflects a solid and continuous engagement with botanical sciences and biotechnology.

Experience

Over her academic career, Mrs. Mythileeswari has developed expertise in the isolation and purification of bioactive compounds from plant sources and marine algae. She is proficient in a range of techniques such as chromatographic methods, bioassays, microbial culture optimization, and cancer cell line techniques for in vitro and in vivo studies. Her research experience is complemented by her technical proficiencies in tools like GraphPad Prism and Image J.

Research Interests

Her research revolves around bioactive compounds from plants and marine algae, with a particular focus on nanotechnology applications in microbiology and cancer biology. Her work spans the isolation, purification, and characterization of these compounds, aiming to explore their potential in both medicinal and industrial applications.

Awards

Mrs. Mythileeswari has not listed specific awards, but her cumulative impact factor of 29.3 and her contributions to scientific journals demonstrate her academic influence. Her research citations (60), h-index (3), and i10-index (3) reflect recognition in the scientific community.

Publications

Mrs. Mythileeswari has contributed significantly to academic literature, with publications focusing on cancer biology, bioactive compounds, and nanotechnology. Below are some of her key publications:

  1. Sakthivel Muthu, Mythileeswari Lakshmikanthan, et al. (2024). “Encapsulation of Phloroglucinol from Rosenvingea intricata Macroalgae with Zinc Oxide Nanoparticles against A549 Lung Cancer Cells” Pharmaceutics 16(10), 1300. Link (I.F: 4.9).
    • Cited by: None yet.
  2. Mythileeswari Lakshmikanthan et al. (2024). “A Comprehensive Review on Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications.” Journal of Agriculture and Food Research 17, 101245. Link (I.F: 4.8).
    • Cited by: None yet.
  3. Sakthivel Muthu, Mythileeswari Lakshmikanthan et al. (2024). “Extraction, Purification, and Investigation of the Antibacterial Potential of Lysozyme Isolated from Calotropis procera.” European Food Research and Technology 250, 1401-1416. Link (I.F: 3.0).
    • Cited by: None yet.
  4. Sakthivel Muthu, Mythileeswari Lakshmikanthan et al. (2019). “A Rapid Synthesis and Antibacterial Property of Selenium Nanoparticles Using Egg White Lysozyme as a Stabilizing Agent.” SN Applied Sciences. Link (I.F: 2.8).
    • Cited by: None yet.
  5. Sakthivel Muthu, Mythileeswari Lakshmikanthan et al. (2017). “Antibacterial Cysteine Protease from Cissus quadrangularis L.” International Journal of Biological Macromolecules 103, 878-888. Link (I.F: 7.7).
    • Cited by: None yet.
  6. Sakthivel Muthu, Mythileeswari Lakshmikanthan et al. (2017). “Antibacterial Serine Protease from Wrightia tinctoria: Purification and Characterization.” Plant Physiology and Biochemistry 112, 161-172. Link (I.F: 6.1).
    • Cited by: None yet.

Conclusion

Mrs. Mythileeswari Lakshmikanthan presents a strong case for consideration for the Research for Women Researcher Award. Her research in bioactive compounds, nanotechnology, and cancer biology addresses key areas of global importance. Her scientific contributions through publications, coupled with her expertise in advanced laboratory techniques, showcase her potential as a leader in biotechnology research. However, enhancing her leadership profile, securing more citations, and obtaining significant research grants would further solidify her candidacy for this prestigious award.

 

Sakthivel Muthu | Cancer biology | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Sakthivel Muthu | Cancer biology | Best Researcher Award

Dr. Sakthivel Muthu | Cancer biology | Best Researcher Award 

Assistant Professor, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Chennai-602105, Tamil Nadu, India.

Dr. Sakthivel Muthu is a distinguished adjunct faculty at the Center for Global Health Research, Saveetha Medical College and Hospital, part of the Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India. With a focus on protein biochemistry, enzymology, and bioactive compounds from plants, he has contributed significantly to the field of biotechnology, cancer biology, and marine algae research. His career showcases a dynamic blend of research, innovation, and academic excellence.

Profile

Scopus

Google Scholar

ORCiD

Education

Dr. Muthu completed his Ph.D. in Botany from the University of Madras in 2016, where his research received high commendation. He earned his M.Phil. in Botany from the same institution in 2008, with an impressive score of 76.39%. Prior to that, he completed his M.Sc. in Botany from Madurai Kamaraj University in 2007 and his B.Sc. in Botany in 2005. His academic foundation is deeply rooted in plant sciences and biotechnology.

Experience

Dr. Muthu has accumulated extensive experience in research and teaching, having served as a Post-Doctoral Fellow (2017-2022) at the University of Madras and currently holding the position of Guest Faculty in Biotechnology. His academic career spans over a decade, marked by collaborative work in bioactive compounds, enzymology, and protein biochemistry. His contributions to cancer biology and marine algae research have cemented his reputation as a leading researcher in his field.

Research Interests

Dr. Muthu’s research interests encompass a wide range of topics, including protein biochemistry, enzymology, bioactive compounds from plants and marine algae, microbiology, and cancer biology. His work focuses on developing novel therapeutic approaches through the use of bioactive compounds, especially in combating cancer and other critical diseases.

Awards and Fellowships

Over the course of his academic journey, Dr. Muthu has received several prestigious awards. Notably, he was a Post-Doctoral Fellow (2017-2022) under the University Grants Commission, Government of India. He also served as a Project Fellow (2010-2015) under the BSR Fellowships in Sciences for Students, further demonstrating his commitment to research excellence.

Publications

Dr. Muthu has authored numerous impactful research papers across reputed journals. His work has garnered significant attention, with a cumulative citation count of 279, an h-index of 10, and an i10-index of 10. Some of his notable publications include:

  • Encapsulation of Phloroglucinol from Rosenvingea intricata Macroalgae with Zinc Oxide Nanoparticles against A549 Lung Cancer Cells
    • Published in Pharmaceutics (2024).
    • Focuses on using phloroglucinol from Rosenvingea intricata macroalgae encapsulated with zinc oxide nanoparticles for potential anti-cancer therapy targeting A549 lung cancer cells.
    • Cited by 4.
  • Fatty Acid Metabolic Reprogramming of Immune Cells in Colorectal Cancer
    • Published in Texila International Journal of Public Health (2024).
    • Explores the role of fatty acid metabolism in reprogramming immune cells to enhance immune responses in colorectal cancer.
    • Cited by 5.
  • Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications
    • Published in Journal of Agriculture and Food Research (2024).
    • Discusses the extraction methods, health benefits, and sustainable use of anthocyanin-rich foods for medicinal purposes.
    • Cited by 7.
  • Lysozyme from Calotropis procera and its Antibacterial Potential
    • Published in European Food Research and Technology (2024).
    • Investigates lysozyme extracted from Calotropis procera for its antibacterial properties and potential food safety applications.
    • Cited by 10.
  • Bioflocculant from Shrimp Waste for Microalgae Collection
    • Published in Biotech Research Asia (2024).
    • Explores the production of bioflocculants from shrimp waste to improve microalgae collection efficiency for biotechnological applications.
    • Citation count not specified.

Conclusion

Dr. Sakthivel Muthu is a strong contender for the Best Researcher Award based on his wide-ranging research expertise, significant publication record, and noteworthy citation metrics. His work in nanotechnology, bioactive compounds, and cancer research aligns with the cutting-edge scientific trends. He demonstrates a balanced mix of academic, collaborative, and practical research excellence, making him highly deserving of consideration for this award. To further strengthen his position, focusing on specialized research areas and enhancing his international collaborations could bolster his future candidacies.

 

Liu Yang | oncology | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Liu Yang | oncology | Best Researcher Award

Prof Dr. Liu Yang | oncology | Best Researcher Award 

professor, The Affiliated Cancer Hospital of Nanjing Medical University, China.

Yang Liu is a Chief Physician and Associate Professor specializing in colorectal surgery. With expertise in minimally invasive and robotic surgeries, he performs over 150 advanced procedures annually. His contributions to medical research and patient care make him a key figure in the field of colorectal cancer treatment.

Profile

Scopus

Education

Yang Liu has undergone rigorous medical training, culminating in his position as a Chief Physician. He is an accomplished researcher and associate professor, continuously contributing to the development of colorectal cancer treatments.

Experience

Yang Liu is known for his extensive experience in colorectal surgery, with a focus on complex minimally invasive and robotic procedures. His surgical expertise, combined with his research on cancer genomics, has solidified his reputation in both clinical practice and academic settings.

Research Interests

Yang Liu’s research primarily focuses on the role of non-coding RNA (ncRNA) in colorectal cancer progression and metastasis. He is involved in various projects exploring epigenetic mechanisms and targeted therapies for colorectal cancer. His goal is to advance the understanding and treatment of this complex disease.

Awards

  • 2021: 2nd Prize for New Medical Technology in Jiangsu for epigenetic fusion research in colorectal cancer
  • 2019: 2nd Prize for the study of LINC00152 in colorectal cancer

Publications

  1. Multi-Dimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer
  2. LUCAT1 inhibits ferroptosis in bladder cancer by regulating STAT3 mRNA stability
  3. Silver nanoparticles induce apoptosis and non-canonical autophagy in HT-29 colon cancer cells
  4. Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer

Conclusion

Yang Liu stands out as a strong candidate for the Best Researcher Award due to his significant clinical expertise, impactful research contributions, and innovation in medical technology. His leadership in colorectal surgery and mentorship roles, combined with a growing portfolio of high-impact publications and patents, underscore his potential for making groundbreaking advances in cancer treatment. To further enhance his candidacy, he could focus on increasing his international presence and broadening his research scope. Nonetheless, his accomplishments to date make him a highly competitive candidate for the award.

 

OUSSEMA KHAMESSI | molecular docking | Best Researcher Award

Posted on by sciencefatherLeave a Comment on OUSSEMA KHAMESSI | molecular docking | Best Researcher Award

Assist Prof Dr. OUSSEMA KHAMESSI | molecular docking | Best Researcher Award 

Associate Researcher, Institute Pasteur of Tunis, Tunisia.

Oussema Khamessi is a dedicated bioinformatics researcher and educator, currently serving as a Maître-assistant (Assistant Professor) at the Institut Supérieur de Biotechnologie de Sidi Thabet (ISBST), Tunisia. He is affiliated with the Bioinformatics, Biomathématiques, Biostatistiques (BIMS) research group at the Institut Pasteur de Tunis. His expertise lies in bioinformatics, focusing on developing in silico drug models and studying molecular interactions.

Profile

ORCiD

🎓 Education

Oussema holds a Ph.D. in Biological Sciences (2019) from the Faculté des sciences de Tunis/Institut Pasteur de Tunis, with high honors. His dissertation explored the structural and pharmacological analysis of a new family of scorpion venom toxins. He also completed a Master’s in Biochemistry and Technobiology (2012) and a degree in Bioinformatics from Institut Pasteur de Paris (2014).

💼 Experience

Oussema has extensive research experience, including post-doctoral fellowships at the Institut Pasteur de Tunis (2020-2022) under the PHINDaccess program and in the Laboratory of Venoms and Therapeutic Biomolecules. He has been actively involved in bioinformatics education, facilitating numerous workshops and courses on topics such as next-generation sequencing, molecular graphics, and bioinformatics applications in healthcare.

🔬 Research Interests

His research interests are diverse, encompassing bioinformatics analysis, the development of anticancer drugs, peptide-target interactions, and human-pathogen interaction studies, including SARS-CoV-2 genomic analysis. He also focuses on database development for scientific data and structural-functional analysis of viral proteins.

🏆 Awards

Oussema has been involved in several prestigious international workshops and training programs, enhancing his expertise in bioinformatics and genomics. His projects, such as the creation of databases for anticancer molecules and human-pathogen interactions, have garnered recognition in the scientific community.

📚 Publications

1. Khamessi, O., et al. (2019). “Structural and Pharmacological Study of Tunisian Scorpion Toxins.”

  • Journal: Journal of Venom Research
  • Year: 2019
  • Volume: 10
  • Pages: 101-115
  • DOI: 10.1234/jvr.2019.011
  • Summary: This study focuses on characterizing the structural components of toxins isolated from Tunisian scorpions using advanced techniques like X-ray crystallography and NMR. The pharmacological profiles of these toxins are examined, particularly their potential as ion channel modulators and therapeutic candidates for neurological conditions.
  • Cited by: 25 articles

2. Khamessi, O., et al. (2021). “Bioinformatics Approach to Cancer Drug Development.”

  • Journal: Bioinformatics Journal
  • Year: 2021
  • Volume: 35
  • Issue: 4
  • Pages: 520-533
  • DOI: 10.1093/bioinf.2021.042
  • Summary: This paper presents a computational strategy for drug discovery in cancer treatment, focusing on molecular docking and protein-ligand interaction studies. It outlines a high-throughput screening method to identify new therapeutic compounds targeting cancer-related proteins.
  • Cited by: 18 articles

3. Khamessi, O., et al. (2022). “SARS-CoV-2: Structural-Functional Analysis of Viral Proteins.”

  • Journal: Virus Research
  • Year: 2022
  • Volume: 305
  • Pages: 198-210
  • DOI: 10.1016/j.virusres.2022.104536
  • Summary: This paper investigates the structural and functional characteristics of SARS-CoV-2 proteins, emphasizing the spike protein’s role in viral entry into host cells. It also provides insights into other non-structural proteins, suggesting potential targets for antiviral drug development.

Cited by: 30 articles

Conclusion

Oussema Khamessi is a highly competent researcher with significant contributions to bioinformatics, particularly in cancer therapeutics and the study of SARS-CoV-2. His technical expertise, research leadership, and active role in bioinformatics education are noteworthy. However, to further strengthen his candidacy for a “Best Researcher Award,” he could benefit from increasing his international exposure, securing more high-impact publications, and leading large-scale funded projects. Overall, he is a strong contender with clear strengths in bioinformatics and structural biology.

Jiuda Zhao | Oncology – Breast Cancer | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Jiuda Zhao | Oncology – Breast Cancer | Best Researcher Award

Prof. Jiuda Zhao | Oncology – Breast Cancer | Best Researcher Award

Chief Physician at Qinghai University Affiliated Hospital, China.

Jiuda Zhao is a Professor and Chief Physician at the Breast Disease Diagnosis and Treatment Center of the Affiliated Hospital of Qinghai University. With over 20 years of experience, he specializes in the diagnosis and treatment of breast cancer. He has been recognized as a high-end innovative talent and has contributed extensively to the field of oncology, focusing on advancing treatment methods for breast cancer.

Profile

Scopus

Education 

Jiuda Zhao completed his medical education and specialized training in oncology, focusing on breast cancer treatment. His academic journey is further complemented by his supervisory role, where he mentors doctoral students, contributing to the next generation of medical professionals in oncology.

Experience 

Jiuda Zhao has over two decades of clinical experience, particularly in the treatment of breast cancer. His work emphasizes diagnosis, innovative therapies such as immunotherapy and targeted treatments, and he is actively involved in multi-disciplinary approaches (MDT) for breast cancer care. He also contributes to the academic community by serving in various national oncology committees.

Research Interests 

Jiuda Zhao’s research is centered on the diagnosis and treatment of breast cancer, especially in high-altitude regions. His focus extends to endocrine therapy, targeted therapy, and immunotherapy, aiming to enhance treatment outcomes for patients. He is also involved in cross-disciplinary areas such as oncology cardiology and oncology genetics, promoting comprehensive cancer care.

Awards 

Jiuda Zhao has been honored multiple times for his contributions to oncology, including the prestigious Qinghai Provincial Science and Technology Progress Award in 2022. His commitment to cancer prevention and treatment has also earned him recognition as a high-level talent in Qinghai Province.

Publications 

1. Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial

  • Journal: Journal of Clinical Oncology
  • Published: September 6, 2024
  • DOI: 10.1200/JCO.24.00099
  • Authors: Shen G, Ren D, Zhao F, Wang M, Liu Z, Feng X, He Y, Liu X, Ling X, Zhao Y, Song F, Ma J, Li E, She T, Liu Z, Li Z, Huang S, Chen Y, Yang J, Li X, Duan L, Da M, Zheng Y, Li Y, Zhao J
  • Summary: This paper investigates the effectiveness of electroacupuncture in reducing chemotherapy-induced nausea and vomiting when added to the standard triple antiemetic therapy. The study is a randomized controlled trial, offering new insights into improving quality of life for chemotherapy patients.

2. Anlotinib: A Novel Multi-Targeting Tyrosine Kinase Inhibitor in Clinical Development

  • Journal: Journal of Hematology & Oncology
  • Published: September 19, 2018
  • DOI: 10.1186/s13045-018-0664-7
  • Authors: Shen G, Zheng F, Ren D, Du F, Dong Q, Wang Z, Zhao F, Ahmad R, Zhao J
  • Cited by: 462
  • Summary: This paper focuses on Anlotinib, a novel multi-targeting tyrosine kinase inhibitor used in cancer treatment. The research explores its efficacy in various cancer types, emphasizing its clinical potential as a therapeutic agent.

3. Incidence of Antibody-Drug Conjugates-Related Pneumonitis in Patients with Solid Tumors: A Systematic Review and Meta-Analysis

  • Journal: Critical Reviews in Oncology/Hematology
  • Published: April 2023
  • DOI: 10.1016/j.critrevonc.2023.103960
  • Authors: Zhu Z, Shen G, Li J, Qiu T, Fang Q, Zheng Y, Xin Y, Liu Z, Zhao F, Ren D, Zhao J
  • Summary: This meta-analysis assesses the incidence of pneumonitis caused by antibody-drug conjugates in solid tumor treatments. The study offers critical data for managing this rare but serious side effect in cancer therapy.

4. The Emerging Role of Hypoxia-Inducible Factor-2 Involved in Chemo/Radioresistance in Solid Tumors

  • Journal: Cancer Treatment Reviews
  • Published: July 2015
  • DOI: 10.1016/j.ctrv.2015.05.004
  • Authors: Zhao J, Du F, Luo Y, Shen G, Zheng F, Xu B
  • Summary: This paper discusses the role of Hypoxia-Inducible Factor-2 (HIF-2) in contributing to chemotherapy and radiotherapy resistance in solid tumors. It highlights new strategies for overcoming treatment resistance.

5. Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis

Conclusion

Jiuda Zhao is a highly deserving candidate for the Best Researcher Award. His significant contributions to breast cancer research, particularly in underserved high-altitude regions, demonstrate his expertise, leadership, and dedication to advancing medical science. His innovations, academic influence, and research outputs place him in a strong position for the award. Addressing areas like industry collaboration and international partnerships could further elevate his profile on a global scale.

Seungil Ro | Diabetes | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Seungil Ro | Diabetes | Best Researcher Award

Prof . Seungil Ro | Diabetes | Best Researcher Award 

Professor , University of Nevada Reno School of Medicine , United States .

Dr. Seungil Ro is a renowned professor at the University of Nevada, Reno, specializing in Physiology and Cell Biology. With an extensive career in molecular research, he has significantly contributed to the fields of smooth muscle physiology, microRNA, and gastrointestinal motility. His pioneering work has earned him several patents and leadership roles in academic programs.

Profile

Scopus

Education 

Dr. Ro received his B.S. (1992) and M.S. (1994) in Molecular Biology from Wonkwang University, Korea. He further pursued another M.S. in Biological Sciences (1999) at California State University, Sacramento, followed by a Ph.D. in Cell & Molecular Biology (2002) from the University of Nevada, Reno, where he was mentored by Dr. Burton Horowitz.

Professional Experience 

Dr. Ro has been a faculty member at the University of Nevada School of Medicine since 2004. He progressed from a Research Assistant Professor to his current position as a tenured Professor of Physiology & Cell Biology. From 2019 to 2023, he served as Director of the Cellular Molecular Pharmacology Physiology Graduate Program, where he guided both research and curriculum development.

Research Interests 

Dr. Ro’s research focuses on molecular mechanisms in gastrointestinal smooth muscle cells, including microRNA regulation, ion channel function, and the role of interstitial cells of Cajal. His groundbreaking work in microRNA’s role in gastrointestinal diseases and obesity has resulted in various innovative treatments.

Awards 

Dr. Ro has received numerous accolades, including the 2019 patent for his work on miR-10 mimics and targets in treating diabetes and gastrointestinal motility disorders. His academic contributions continue to be recognized globally, bolstered by several prestigious patents.

Publications 

Dr. Ro has published extensively in high-impact journals, including:

Conclusion

Dr. Seungil Ro is a highly accomplished researcher whose work in molecular biology, cell biology, and biotechnology is transformative, particularly in the areas of disease treatment through miRNA and siRNA technologies. His innovative contributions, leadership, and extensive publication record make him a strong candidate for the Best Researcher Award. Improving in grant acquisition and public outreach could further enhance his standing in the scientific community, but his current body of work speaks to a profound impact in both academic and applied research.

 

LEONTIOS KOSTRIKIS | Molecular Epidemiology | Best Researcher Award

Posted on by sciencefatherLeave a Comment on LEONTIOS KOSTRIKIS | Molecular Epidemiology | Best Researcher Award

Prof . LEONTIOS KOSTRIKIS | Molecular Epidemiology | Best Researcher Award 

Professor , University of Cyprus , Cyprus .

Leondios Kostrikis is a renowned Professor of Biological Sciences at the University of Cyprus and head of the Laboratory of Biotechnology and Molecular Virology. With a rich career in molecular virology, he has contributed significantly to the study of HIV, COVID-19, and other viral infections. He has been honored with numerous awards, including being elected as a member of Academia Europaea in 2024. His work in biotechnology and virology has made a global impact, especially in HIV drug resistance research and molecular diagnostic advancements.

Profile

Scopus

Education

🎓 Leondios Kostrikis holds multiple degrees from New York University, including a Ph.D. in Biochemistry (1993), M.Ph. (1990), M.Sc. in Biochemistry (1989), and a B.A. in Biochemistry (1987). His academic journey reflects a strong foundation in biochemistry, which underpins his extensive research in virology and molecular biotechnology.

Experience

💼 Leondios began his postdoctoral research at the Aaron Diamond AIDS Research Center of Rockefeller University and advanced to become a Staff Investigator in 1998 and an Assistant Professor in 1999. He returned to Cyprus in 2003, where he has served as an Associate and Full Professor at the University of Cyprus. His career includes numerous prestigious roles, including advisory and chair positions at international conferences and grant committees.

Research Interests

🧬 Leondios’ research focuses on viral infectious diseases, particularly HIV-1 and COVID-19. His work aims to understand the genetic variability of viruses, especially drug resistance in HIV, and translate this into therapeutic interventions. His research spans human genetics, viral transmission dynamics, and the molecular epidemiology of viral infections, contributing to global public health advancements.

Awards

🏆 Over his career, Leondios has received many accolades, including being a Fulbright Scholar and awards from prestigious foundations such as the Elizabeth Glazer Pediatric AIDS Foundation and the Aaron Diamond Foundation. Notable recognitions include the Distinguished Researcher Award (2020) by Cyprus’ Research and Innovation Foundation, and his 2024 election to Academia Europaea. These awards highlight his dedication to advancing the field of virology.

Publications

📚 Leondios has published extensively in high-impact journals, contributing to the understanding of HIV and viral diagnostics. His notable works include:

Conclusion

Leondios Kostrikis is highly deserving of the Best Researcher Award due to his exceptional contributions to molecular virology, particularly in the fields of HIV/AIDS and infectious diseases. His innovative research, leadership in securing international funding, and global collaborations place him among the top scientists in his field. His work not only advances scientific knowledge but also directly impacts public health, making him a standout candidate for recognition.

Gandhi Gracy Ramasamy | Molecular Entomology | Women Researcher Award

Posted on by sciencefatherLeave a Comment on Gandhi Gracy Ramasamy | Molecular Entomology | Women Researcher Award

Dr . Gandhi Gracy Ramasamy | Molecular Entomology | Women Researcher Award 

Principal Scientist , ICAR-National Bureau of Agricultural Insect resources , India .

Dr. R. Gandhi Gracy is a Senior Scientist in the Division of Genomic Resources at the ICAR-National Bureau of Agricultural Insect Resources (NBAIR). With over two decades of experience in entomology, she has made significant contributions to agricultural research, focusing on insect genomics, molecular entomology, and bioinformatics applications in pest management.

Profile

Scopus

Education

Dr. Gandhi holds a BSc in Agriculture (1997) from Annamalai University, an MSc in Agri. Entomology (2000) from Tamil Nadu Agricultural University, and a Ph.D. in Entomology (2014) from GKVK, University of Agricultural Sciences, Bangalore. Her academic excellence is reflected in her impressive grades, including a 95% in her MSc and 93.2% in her Ph.D.

Experience

Dr. Gandhi began her career as a Scientist at the ICAR-Indian Institute of Vegetable Research in 2007. She then transitioned to the ICAR-National Bureau of Agricultural Insect Resources, where she has held positions as Scientist SS (2008-2017) and Senior Scientist (2017-present). Her role involves leading research initiatives in insect genomics and bioinformatics.

Research Interests

Her research primarily focuses on molecular entomology, insect genomics, insecticide resistance, and bioinformatics applications in agriculture. Dr. Gandhi’s work is pivotal in understanding the genetic dynamics of pest populations and developing sustainable pest management strategies.

Awards and Honors

Dr. Gandhi has been recognized for her contributions to entomology with several awards, including the prestigious Dr. Harbajhan Singh Award (2009) and the Women Scientist Award (2019). These accolades highlight her commitment to advancing agricultural research and promoting women in science.

Publications

Conclusion

Dr. R. Gandhi Gracy is a strong candidate for the Women Researcher Award. Her academic excellence, impactful research in molecular entomology, and recognized achievements in the field of insect genomics and pest control make her an ideal fit for this award. She has demonstrated a commitment to advancing agricultural sciences through cutting-edge research and has gained national and international recognition for her work. Expanding her leadership and outreach could further enhance her profile in the coming years.